Researchers find genetic mutations which appear to underlie a rare syndrome which combines reproductive failure with cerebella ataxi and dementia.
According to three new studies, numerous opportunities exist to improve the outcomes of TBI in older adults.
Researchers develop new medical records software which helps monitor the health of the aging brain.
Buphenyl (sodium phenylbutyrate), a medication approved for the treatment of hyperammonemia, could help prevent the progression of Alzheimer’s disease, a new study finds.
Researcher discover age related dementia likely occurs due to the declining ability for neurons to dispose of unwanted aggregated proteins.
New research supports the idea that a malfunction of the TDP-43 protein plays a decisive role in the development of ALS and FTD.
A new study identifies a potential treatment window of several years for plaques in the brain considered to cause memory loss in diseases such as Alzheimer’s.
Researchers discover a three molecule complex could be a target for treating Huntington’s Disease, a genetic and currently incurable brain disease which causes movement disorders and dementia.
Researchers combined genetic data with neuroimaging in order to identify genes associated with amyloid plaque deposits in Alzheimer’s disease patients. The study is believed to be the first genome-wide association study of plaque deposits using a specialized PET scan tracer that binds to amyloid.
A new study suggest that along with amyloid deposits, white matter hyperintensities may be a second necessary factor for the development of Alzheimer’s disease.